Abstract
Infantile hemangioma is the most common pediatric vascular tumor, with the following risk factors: low birth weight, prematurity, white skin, female gender, multiparity and advanced maternal age. The use of oral and topical beta-blockers, although recent, has emerged as the first line of treatment, with superior safety and efficacy to previously used therapies, such as corticosteroids and surgeries. This report describes two cases of nasal tip infantile hemangioma, treated with oral propranolol. Both presented excellent therapeutic responses.
Highlights
Infantile Hemangioma (IH) is the most common pediatric vascular tumor, affecting mainly the nasal tip and head, with incidence of 3% to 10%
The clinical course of IH is divided into three phases
Ulcerations, bleeding and obstruction of vital structures can occur during this phase, especially in preterm infants
Summary
Infantile Hemangioma (IH) is the most common pediatric vascular tumor, affecting mainly the nasal tip and head, with incidence of 3% to 10%. Success in the use of oral propranolol in the treatment of infantile hemangioma in nasal tip --- Report of two cases. The plateau phase (in which there is no regression or evolution) arises in approximately 10% of cases, requiring therapeutic intervention, as there is a risk of permanent deformation.1---3
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
